Engineered Small Extracellular Vesicles as a FGL1/PD-L1 Dual-Targeting Delivery System for Alleviating Immune Rejection.
Tsai HI, Wu Y, Liu X, Xu Z, Liu L, Wang C, Zhang H, Huang Y, Wang L, Zhang W, Su D, Khan FU, Zhu X, Yang R, Pang Y, Eriksson JE, Zhu H, Wang D, Jia B, Cheng F, Chen H.
Tsai HI, et al.
Adv Sci (Weinh). 2022 Jan;9(3):e2102634. doi: 10.1002/advs.202102634. Epub 2021 Nov 5.
Adv Sci (Weinh). 2022.
PMID: 34738731
Free PMC article.